Heidelberg Pharma AG(GB:0QW5)
€2.06-0.02 (-0.96%)
GB:0QW5
Heidelberg Pharma AG earnings date
€2.06
At close:-0.02 (-0.96%)
Heidelberg Pharma AG (0QW5) Earnings Dates, Call Summary & Reports
0 Followers
Earnings Data
- Report Date
- ―
- Period Ending
- ―
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- ―
TBA (Not Confirmed)
Same Quarter Last Year
Heidelberg Pharma AG (GB:0QW5) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
GB:0QW5 Q2 2026 Earnings Report
GB:0QW5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | 2026 (Q2) | ―0.02 | -0.14 | 112.59% (+0.16) | ― | ― | |
| Mar 26, 2026 | 2025 (Q4) | ―-0.09 | -0.13 | 28.35% (+0.04) | ― | ― | |
| Jul 10, 2025 | 2025 (Q2) | ―-0.14 | -0.09 | -58.89% (-0.05) | ― | ― | |
| Mar 21, 2025 | 2024 (Q4) | ―-0.13 | -0.1 | -32.29% (-0.03) | ― | ― | |
| Oct 03, 2024 | 2024 (Q3) | ―- | ― | ― | ― | ― | |
| Jul 11, 2024 | 2024 (Q2) | ―-0.09 | -0.2 | 55.45% (+0.11) | ― | ― | |
| Mar 25, 2024 | 2023 (Q4) | ―-0.10 | -0.14 | 31.91% (+0.04) | ― | ― | |
| Oct 12, 2023 | 2023 (Q3) | ―- | -0.14 | ― | ― | ― | |
| Jul 13, 2023 | 2023 (Q2) | ―-0.20 | -0.04 | -405.00% (-0.16) | ― | ― | |
| Mar 24, 2023 | 2022 (Q4) | ―-0.14 | -0.21 | 33.49% (+0.07) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
GB:0QW5 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jul 15, 2026 | €2.77 | €2.77 | +0.00% |
| Mar 26, 2026 | €2.99 | €2.86 | -4.35% |
| Jul 10, 2025 | €4.88 | €4.84 | -0.82% |
| Mar 21, 2025 | €2.56 | €2.67 | +4.30% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.

